Cell Analysis Instruments Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The cell analysis instruments market is expected to register a CAGR of 7.1% over the forecast period.

COVID-19 had a significant impact on the cell analysis instruments market since cell count and viability tests were widely carried out during the pandemic. According to an article published in February 2022 in News Medical life sciences, the number of WBC cell counts is a crucial indicator of inflammation; higher than 11,000 WBCs per unit microliter of blood counts may affect COVID-19 patients' hospital discharge and mortality rates. Similarly, as per an article published in June 2021 in the BMC journal, a higher WBC count (≥ 6.16 × 10^9/L) should be given more attention in the treatment of COVID-19. Developments such as these put cell analysis at the forefront during the pandemic and have contributed greatly to the growth of the market, which is expected to continue its positive, upward trend in the coming years.

Another factor that has played into the growth of the market is the growing burden of cancer across the globe and the expanding biotech industry and research in cell biology. For instance, per an American Cancer Society 2022 update, 1,918,030 new cancer cases were estimated in the United States in 2022. Furthermore, cell analysis in cancer is widely used by researchers to identify various criteria. An article published in November 2022 in the Nature journal mentioned that researchers performed a pan-cancer analysis on 226 samples across 10 solid cancer types to profile the tumor microenvironment (TME) at single-cell resolution, illustrating the commonalities/plasticity of heterogenous CAFs (cancer-associated fibroblasts).

Furthermore, product launches, strategic collaborations, and acquisitions by key players are expected to drive market growth over the forecast period. For instance, in August 2022, DeNovix Inc, the manufacturer of the award-winning CellDrop Automated Cell Counter, developed two dedicated nuclei counting apps capable of differentiating isolated nuclei and intact cells from debris. The CellDrop Series is a line of image-based, automated cell counters. Systems include a high-definition 7-inch touchscreen for live preview and instant review of results.

While several developments predict growth, the high cost of cell analysis and complex regulatory scenarios are anticipated to restrain the market growth over the forecast period.

Cell Analysis Instruments Market Trends

The Cell Counting Segment is Expected to Register a Significant Growth During the Forecast Period

Cell counting is done to compare different cell populations or responses. It is fundamental and critical to numerous biological experiments. Cell counting is done by various methods, such as automated cell counters, cell cycle analysis, and counting cells without cell staining. Cell counting is used in medicine to understand the concentration of blood cells, which can provide crucial information about the health situation of a person. In cell therapy, it is used to control the dosage of cells given to the patient. The cell counting segment is anticipated to witness significant growth in the market owing to factors such as a rise in chronic diseases and an increase in the biotech industry and research in cell biology. For instance, as per an article published in February 2022 in Frontiers journal, a high WBC count is positively related to an increased risk of insulin resistance among middle-aged and older people in Taiwan.

Furthermore, an increase in cancer studies involving cell counting is expected to push segment growth over the forecast period. For instance, as per an article published in December 2022 in ASCO Post, a single evaluation of the (circulating tumor cell) count prior to the start of treatment can help patients with (estrogen receptor)-positive/HER2-negative metastatic breast cancer decide between chemotherapy and single-agent endocrine therapy, according to the STIC trial, which is the first to demonstrate the clinical utility of the count as a biomarker in breast cancer care.

Moreover, the major players in the market are concentrating on introducing new technological advancements to improve their market share. For instance, in March 2022, Mindray launched the new BC-700 Series, a revolutionary hematology analyzer series that incorporates complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests.

North America is Anticipated to Hold a Major Share in the Cell Analysis Instruments Market Over the Forecast Period

North America is expected to hold a significant market share over the forecast period due to the increase in incidences of cancer and increasing corporate and government funding in cell-based research. For instance, according to the Canadian Cancer Statistics 2022 Special Report, the number of people living with and after cancer in Canada continued to grow to over 1.5 million people. It was estimated that 233,900 people were likely to be diagnosed with cancer in 2022.

Due to the presence of major companies, their product launches, and the strong R&D in biotechnology, the country is witnessing rapid growth in the market studied. For instance, in September 2022, Becton, Dickinson, and Company launched BD Research Cloud, a cloud-based software solution designed to streamline the flow cytometry workflow to enable higher-quality experiments with faster time to insight for scientists working across a range of disciplines, including immunology, virology, oncology, and infectious disease monitoring.

Furthermore, in December 2022, Asymmetrex planned to develop the first therapeutic stem cell counter based on a new report of validation of rapid stem cell-counting technology. Asymmetrex’s newest report on its kinetic stem cell (KSC) counting technology for determining the dosage of therapeutic stem cells was published online in the Journal of Stem Cell Therapy and Transplantation. The company’s scientists used commercial preparations of cord blood stem cells and adult blood stem cells to validate its recently reported mathematical equations for the calculation of the dosage of therapeutic stem cells.

Cell Analysis Instruments Industry Overview

The market for cell analysis instruments is moderately competitive and consists of local as well as global players. Developing countries have a large number of local players catering to consumers across laboratories and academia. However, the largest share of the market on the global scale is held by international companies such as Thermo Fisher Scientific, Sartorius AG, Danaher Corporation, etc. With advancements being made in the biotech industry, it is believed that there will be an emergence of new players in the future.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.